Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Acute Stroke
Open-data reference.
11 US clinical trials · 5 currently recruiting
Active & Recent Trials
Stroke Recovery Initiative - Registry for Stroke Research Studies
University of California, San Francis
NCT03318432
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
DiaMedica Therapeutics
NCT05065216
Sensory-Motor Rehabilitation Post Stroke
University of Maryland, Baltimore
NCT02369770
SEACOAST 1- SEdAtion With COllAteral Support in Endovascular Therapy for Acute Ischemic Stroke
University of California, Los Angeles
NCT03737786
Ischemic Conditioning During Air tRansport Save penUmbral Tissue
Enrique Leira
NCT03481205
Blood Pressure After Endovascular Stroke Therapy-II
University of Cincinnati
NCT04116112
Robot Assisted Upper Limb Neuro-Rehabilitation
US Department of Veterans Affairs
NCT00011583
The Capillary Index Score Trial
Firas Al-Ali
NCT02618031
Non-invasive Brain Stimulation and Occupational Therapy To Enhance Stroke Recovery
Beth Israel Deaconess Medical Center
NCT00792428
Metabolic Costs of Walking Post Stroke
University of Texas Southwestern Medical Center
NCT02108912
Beta-hCG + Erythropoietin in Acute Stroke
University of California, Irvine
NCT00362414
Phase Distribution
| Phase | Trial count |
|---|---|
| Early Phase 1 | 1 |
| Phase 2 | 4 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Acute Stroke Trial Landscape
ClinicalTrials.gov lists 11 US studies indexed under Acute Stroke, and 5 of those are currently open to recruitment — roughly 45% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Acute Stroke shows 0 late-stage studies (Phase 3 and Phase 4 combined) alongside 5 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Acute Stroke is led by Firas Al-Ali with 1 indexed trial, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 11 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Acute Stroke?
PlainTrial tracks 11 US clinical trials for Acute Stroke, of which 5 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Acute Stroke?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.